Frovatriptan Succinate
Who holds supplier records for Frovatriptan Succinate? 3 organisations hold a current record for Frovatriptan Succinate: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (3).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Frovatriptan Succinate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/frovatriptan-succinate
Reading the evidence
- 3 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
3 of the 3 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 1 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (3)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Frovatriptan Succinate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ALIVUS LIFE SCIENCES LTDIndia Company GMP cert on recordActive DMF 22952 · latest filing Jul 2009
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaActive DMF 27284 · latest filing Jul 2013
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 24311 · latest filing Oct 2010
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Frovatriptan Succinate is a selective 5-HT receptor agonist used to treat migraine attacks. It has a higher affinity for the 5-HT1B and 5-HT1D receptors, contributing to its efficacy in alleviating headache symptoms.
Chemical identity
- IUPAC name
- butanedioic acid;(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide;hydrate
- Canonical SMILES
- CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N.C(CC(=O)O)C(=O)O.O
- InChIKey
- CUETXFMONOSVJA-KLQYNRQASA-N
- Synonyms
- Frova API, frova, frovatriptan succinate hydrate, frovatriptan succinate monohydrate, frovelan, migard, miguard, nsc-760422, sb 209509 ax, sb 209509-ax, sb-209509-ax, sb-209509ax
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Serotonin-1b and Serotonin-1d Receptor Agonist
- Mechanism of action
- Serotonin 1b Receptor Agonists; Serotonin 1d Receptor Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Frovatriptan Succinate?
3 organisations hold an active US FDA Type II Drug Master File or a CEP for Frovatriptan Succinate: ALIVUS LIFE SCIENCES LTD (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India) and MATRIX PHARMACORP PRIVATE LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Frovatriptan Succinate Drug Master Files are active?
ALIVUS LIFE SCIENCES LTD (DMF 22952), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 27284) and MATRIX PHARMACORP PRIVATE LTD (DMF 24311). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
How do I qualify a Frovatriptan Succinate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Frovatriptan Succinate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.